Advertisement
News and applications for life science research professionals
Subscribe to Bioscience Technology All

The Lead

Imaging and Analysis with Flying Colors: Part One

October 22, 2014 | by Mark Clymer, Director of Marketing, Datacolor Inc. | Articles | Comments

Researchers are facing increasing demands from colleagues, peers and publishers for process documentation including adequate controls, and for extensive documentation of experimental parameters. Without such consideration, there would be little chance to repeat, or even validate, findings.

TOPICS:
View Sample

FREE Email Newsletter Bioscience Technology Daily

Complete Vacuum Concentrators Process Multiple Samples

October 22, 2014 2:58 pm | Product Releases | Comments

The all-in-one CentriVap Complete from Labconco houses every component needed to begin processing multiple samples: vacuum concentrator, cold trap and diaphragm vacuum pump.

Gas Analyzer Ideal for Continuous Flow Monitoring

October 22, 2014 2:48 pm | Product Releases | Comments

The MAX300-EGA from Extrel, designed for evolved gas analysis, delivers precision, stability, speed and flexibility for the analysis of off-gas from a thermal analyzer (TGA) or other continuous flow system.

TOPICS:

Tackling Blindness, Deafness Through Neuroengineering

October 22, 2014 2:26 pm | News | Comments

The Bertarelli Program in Translational Neuroscience and Neuroengineering, a collaborative program between Harvard Medical School and the École Polytechnique Fédérale de Lausanne (EPFL) in Switzerland, has announced a new set of grants worth $3.6 million for five research projects.

TOPICS:
Advertisement

Olive Oil More Stable, Healthful for Frying Food

October 22, 2014 1:52 pm | News | Comments

Before dunking your favorite food in a vat of just any old oil, consider using olive. Scientists are reporting that olive oil withstands the heat of the fryer or pan better than several seed oils to yield more healthful food.       

TOPICS:

Skin Patch May Replace Syringe for Disease Diagnosis

October 22, 2014 1:46 pm | News | Comments

Drawing blood and testing it is standard practice for many medical diagnostics. As a less painful alternative, scientists are developing skin patches that could one day replace the syringe.                  

TOPICS:

CDC: Monitoring for all coming from Ebola nations

October 22, 2014 12:26 pm | by Connie Cass - Associated Press - Associated Press | News | Comments

Federal health officials are significantly expanding the breadth of vigilance for Ebola, saying that all travelers who come into the U.S. from Ebola-stricken West African nations will now be monitored for symptoms of illness for 21 days. The director of the Centers for Disease Control and...

Biogen slides as MS drug is linked to inflammation

October 22, 2014 12:26 pm | by The Associated Press | News | Comments

Shares of Biogen Idec slumped 8 percent Wednesday despite a strong quarter after the pharmaceutical said a patient who took its newest multiple sclerosis drug suffered a brain inflammation and later died. The company confirmed there was a case of progressive multifocal leukoencephalopathy, or...

Dozens released Ebola-free from Sierra Leone site

October 22, 2014 11:27 am | by Kabba Kargbo - Associated Press - Associated Press | News | Comments

FREETOWN, Sierra Leone (AP) — Dozens of Ebola survivors were discharged from a treatment center near Sierra leone's capital on Wednesday and told they were virus-free. The third group released from the Hastings Treatment center, which included 45 patients, were also issued with health...

Advertisement

J&J to spend up to $200M on Ebola vaccine program

October 22, 2014 8:26 am | by The Associated Press | News | Comments

Johnson & Johnson will start safety testing in early January on a vaccine combination that could protect people from a strain of the deadly Ebola virus. The health care products maker says it has committed up to $200 million to speed up and expand production of a vaccine program being...

German firm wins appeal in Spain thalidomide case

October 22, 2014 6:27 am | by The Associated Press | News | Comments

A Spanish court has upheld an appeal by a German pharmaceutical company, ditching a previous ruling that ordered the company to pay compensation to 22 Spaniards who blame their disabilities on the drug thalidomide. Madrid*s provincial court announced the ruling Wednesday, saying the statute of...

Red Cross Official: 6 Months to Contain Ebola

October 22, 2014 3:26 am | by The Associated Press | News | Comments

A top Red Cross official says he is confident the Ebola epidemic can be contained within four to six months. The Ebola outbreak has killed more than 4,500 people since it emerged 10 months ago, with Liberia, Guinea and Sierra Leone the worst-affected countries.

TOPICS:

Ebola airport checks expand; nurses get training

October 22, 2014 3:26 am | by Connie Cass - Associated Press - Associated Press | News | Comments

The federal government is closing a gap in Ebola screening at airports while states from New York to Texas to California work to get hospitals and nurses ready in case another patient turns up somewhere in the U.S. with the deadly disease. Under the rule going into effect Wednesday, air travelers...

Ebola victim's sister says hospital denied request

October 21, 2014 11:26 pm | by Emily Schmall - Associated Press - Associated Press | News | Comments

The family of the first Ebola victim to die in the United States says the hospital that cared for him has refused for weeks to release lab results showing the effects of an experimental drug treatment, fanning their suspicions that the facility mishandled the case. They believe that information...

Third Point urges Amgen to consider breakup

October 21, 2014 8:25 pm | by The Associated Press | News | Comments

A hedge fund run by a famed investor said Tuesday it has taken a large stake in Amgen and now wants the biotech drugmaker to consider splitting up into two. In a letter to investors, Third Point, a hedge fund run by Daniel Loeb, said it has recently increased its stake by an unspecified amount,...

Study finds drugs still in recalled supplements

October 21, 2014 6:25 pm | by Lindsey Tanner - AP Medical Writer - Associated Press | News | Comments

Dietary supplements containing potentially dangerous prescription drug ingredients may still be for sale even years after safety recalls, a study found. In supplements bought online, researchers detected hidden steroids, similar ingredients to Viagra and Prozac and a weight loss drug linked with...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading